Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 4751 - 4775 of 5621 in total

VO659

VO659 is an antisense oligonucleotide being investigated for the treatment of Huntington's disease.
Investigational

DMP-777

DMP-777 is a selective inhibitor of polymorphonuclear leukocyte (PMN) elastase.
Investigational

Tuvusertib

Investigational

S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine

Experimental

Nicotinamide adenine dinucleotide cyclohexanone

Experimental

(5S,6S)-6-[(R)ACETOXYETH-2-YL]-PENEM-3-CARBOXYLATEPROPANE

Experimental

N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine

Experimental

2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE

Experimental

CYCLOHEXYLMETHYL-2,3-DIHYDROXY-5-METHYL-HEXYLAMIDE

Experimental

N-(4-Aminobutanoyl)-S-(4-methoxybenzyl)-L-cysteinylglycine

Experimental

3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One

Experimental

2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside

Experimental

4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL

Experimental

N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID

Experimental

6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE

Experimental

4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine

Experimental

Ethylmercurithiosalicylic acid

Ethylmercurithiosalicylic acid is a topical antiseptic used on skin and mucous membranes. It is also used as a preservative in pharmaceuticals.
Experimental

Gosogliptin

Gosogliptin has been used in trials studying the treatment of Renal Insufficiency, Chronic.
Investigational

Empegfilgrastim

Empegfilgrastim is under investigation in clinical trial NCT01569087 (Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer).
Investigational

Vorasidenib

Investigational

Adenovirus/PNP

Investigational

BB-1701

BB-1701 is a humanized IgG1 kappa monoclonal antibody (anti-HER2 antibody) conjugated to eribulin developed by Bliss Biopharmaceutical.
Investigational

MG-S-2525

Investigational

RGG0853

RGG0853 is an E1A lipid complex, a repressor gene complexed with a cationic lipid vector.
Investigational

Bexicaserin

Bexicaserin is under investigation in clinical trial NCT05626634 (Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy).
Investigational
Displaying drugs 4751 - 4775 of 5621 in total